Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NATUS MEDICAL INCORPORATED

(NTUS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
23.95(c) 23.97(c) 24.38(c) 23.95(c) 23.6(c) Last
155 401 148 360 161 675 213 000 144 604 Volume
-0.33% +0.08% +1.71% -1.76% -1.46% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 471 M - -
Net income 2021 23,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 33,7x
Yield 2021 -
Sales 2022 485 M - -
Net income 2022 37,3 M - -
Net Debt 2022 - - -
P/E ratio 2022 21,5x
Yield 2022 -
Capitalization 797 M 797 M -
Capi. / Sales 2021 1,69x
Capi. / Sales 2022 1,64x
Nbr of Employees 1 420
Free-Float -
More Financials
Company
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and... 
More about the company
Ratings of Natus Medical Incorporated
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about NATUS MEDICAL INCORPORATED
01/10Natus Medical Boosts Q4, Full-Year Revenue Outlook
MT
01/10NATUS MEDICAL INCORPORATED : Announces Preliminary 2021 Fourth Quarter and Full Year Reven..
PU
01/10Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
AQ
01/10Natus Medical Incorporated Provides Preliminary Revenue Guidance for the Fourth Quarter..
CI
01/07Natus to Participate in the 24th Annual Needham Virtual Growth Conference
AQ
01/03Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February..
AQ
2021Natus Medical Names New CEO
MT
2021NATUS MEDICAL INCORPORATED : Announces Executive Transition - Form 8-K
PU
2021NATUS MEDICAL INC : Financial Statements and Exhibits (form 8-K)
AQ
2021Natus Medical Incorporated Announces Resignation of Jonathan A. Kennedy as President an..
CI
2021Natus Medical Incorporated Announces Chief Executive Officer Changes
CI
2021Natus Medical Announces Executive Transition
AQ
2021Natus Medical Incorporated Appoints Thomas J. Sullivan as Chief Executive Officer, Effe..
CI
2021Natus Medical Incorporated Appoints Thomas J. Sullivan as President, Effective December..
CI
2021INSIDER SELL : Natus Medical
MT
More news
News in other languages on NATUS MEDICAL INCORPORATED
01/10Natus Medical revoit à la hausse ses prévisions de revenus pour le quatrième trimestre ..
01/10Natus Medical Incorporated fournit des prévisions de revenus préliminaires pour le quat..
2021Natus Medical affiche des revenus et des bénéfices ajustés plus élevés au troisième tri..
2021GUIDANCE : (NTUS) NATUS MEDICAL INCORPORATED prévoit une fourchette de bénéfices par actio..
2021GUIDANCE : (NTUS) NATUS MEDICAL INCORPORATED prévoit une fourchette de bénéfices par actio..
More news
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 23,60 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
D. Christopher Chung Chief Medical Officer & VP-Regulatory Affairs
Ivan Pandiyan Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED-0.55%797
THERMO FISHER SCIENTIFIC-14.91%223 721
DANAHER CORPORATION-17.57%193 793
INTUITIVE SURGICAL, INC.-26.48%94 361
SIEMENS HEALTHINEERS AG-12.03%73 251
EDWARDS LIFESCIENCES CORPORATION-15.48%68 358